神州泰嶽(300002.SZ):選舉冒大衞為公司第七屆董事會董事長
格隆匯 2 月 28日丨神州泰嶽(300002.SZ)公佈,公司董事會於近日收到了王寧提交的書面辭職報吿,王寧由於年齡原因申請辭去公司第七屆董事會董事長職務,辭去公司董事長職務後,將繼續擔任公司第七屆董事會董事及薪酬與考核委員會委員職務。
2021年2月26日,公司第七屆董事會第四十次會議審議通過了《關於選舉董事長的議案》,為進一步優化幹部結構,經公司董事會研究決定,同意選舉冒大衞為公司第七屆董事會董事長,任期自本次董事會審議通過之日起至本屆董事會任期屆滿時止。
根據《公司章程》的相關規定,董事長為公司的法定代表人。公司將盡快完成法定代表人的工商變更登記手續。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.